These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7567556

  • 1. Advances in the treatment of cystic fibrosis.
    Hopkins S.
    Nurs Times; ; 91(39):40-1. PubMed ID: 7567556
    [Abstract] [Full Text] [Related]

  • 2. Dornase alpha in the management of a mechanically ventilated infant with cystic fibrosis.
    Kling S, Gie RP, Riphagen S.
    Pediatr Pulmonol; 1997 Aug; 24(2):124-5. PubMed ID: 9292906
    [No Abstract] [Full Text] [Related]

  • 3. Dornase alfa: a new option in the management of cystic fibrosis.
    Witt DM, Anderson L.
    Pharmacotherapy; 1996 Aug; 16(1):40-8. PubMed ID: 8700791
    [Abstract] [Full Text] [Related]

  • 4. [Current therapeutic agents: dornase alfa].
    Baran D, Sternon J.
    Rev Med Brux; 1997 Feb; 18(1):37-40. PubMed ID: 9132917
    [Abstract] [Full Text] [Related]

  • 5. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
    Coates AL.
    J Pediatr; 2001 Dec; 139(6):768-70. PubMed ID: 11743499
    [No Abstract] [Full Text] [Related]

  • 6. [New pharmacological approaches: rhDNase].
    Tournier G, Sardet A, Grosskopf C, Baculard A, Delaisi B.
    Rev Pneumol Clin; 1995 Dec; 51(3):193-200. PubMed ID: 7569583
    [Abstract] [Full Text] [Related]

  • 7. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.
    Cimmino M, Nardone M, Cavaliere M, Plantulli A, Sepe A, Esposito V, Mazzarella G, Raia V.
    Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1097-101. PubMed ID: 16365224
    [Abstract] [Full Text] [Related]

  • 8. [Swiss registry for patients with cystic fibrosis: design, programming, implementation and first examples of use].
    Schöni-Affolter F, Oswald P, Wandt-Baumann C, Kriemler S, Schöni MH.
    Schweiz Med Wochenschr; 2000 Sep 30; 130(39):1373-81. PubMed ID: 11059028
    [Abstract] [Full Text] [Related]

  • 9. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW, Pulmozyme Early Intervention Trial Study Group.
    J Pediatr; 2001 Dec 30; 139(6):813-20. PubMed ID: 11743506
    [Abstract] [Full Text] [Related]

  • 10. USAN Council. List No.405. New names. Dornase alfa.
    Clin Pharmacol Ther; 1998 Jun 30; 63(6):705. PubMed ID: 9687230
    [No Abstract] [Full Text] [Related]

  • 11. [Cystic fibrosis--review].
    Jonsdottir B, Bergsteinsson H, Baldursson O.
    Laeknabladid; 2008 Dec 30; 94(12):831-7. PubMed ID: 19182319
    [Abstract] [Full Text] [Related]

  • 12. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
    Fitzgerald DA, Hilton J, Jepson B, Smith L.
    Pediatrics; 2005 Oct 30; 116(4):e549-54. PubMed ID: 16147970
    [Abstract] [Full Text] [Related]

  • 13. [Cystic fibrosis. Current indications for nebulized treatments: antibiotics and DNase].
    Sardet-Frismand A.
    Rev Mal Respir; 1999 Jan 30; 16 Suppl 3():S131-2. PubMed ID: 10088286
    [No Abstract] [Full Text] [Related]

  • 14. Mucolytics in cystic fibrosis.
    Henke MO, Ratjen F.
    Paediatr Respir Rev; 2007 Mar 30; 8(1):24-9. PubMed ID: 17419975
    [Abstract] [Full Text] [Related]

  • 15. Aerosolized deoxyribonuclease for cystic fibrosis.
    Med Lett Drugs Ther; 1994 Apr 15; 36(920):34-5. PubMed ID: 8145672
    [No Abstract] [Full Text] [Related]

  • 16. [Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].
    Derelle J, Bertolo-Houriez E, Marchal F, Weber M, Virion JM, Vidailhet M.
    Arch Pediatr; 1998 Apr 15; 5(4):371-7. PubMed ID: 9759155
    [Abstract] [Full Text] [Related]

  • 17. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
    Bilton D, Stanford G.
    Curr Opin Pulm Med; 2014 Nov 15; 20(6):601-6. PubMed ID: 25221855
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic management of cystic fibrosis.
    Wallace CS, Hall M, Kuhn RJ.
    Clin Pharm; 1993 Sep 15; 12(9):657-74; quiz 700-1. PubMed ID: 8306566
    [Abstract] [Full Text] [Related]

  • 19. Early treatment with dornase alfa in cystic fibrosis: what are the issues?
    Bush A.
    Pediatr Pulmonol; 1998 Feb 15; 25(2):79-82. PubMed ID: 9516089
    [No Abstract] [Full Text] [Related]

  • 20. Dornase alpha and survival of patients with cystic fibrosis.
    McIntyre AM.
    Hosp Med; 1999 Oct 15; 60(10):736-9. PubMed ID: 10656067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.